Shares of Beam Therapeutics Inc (BEAM) jumped more than 10% in pre-market trading on Wednesday, after the biotech firm reported promising early-stage data for its gene-editing therapy (BEAM-302) that ...

Beam Global (BEEM) shares soared 11% in the last trading session to close at $16.09. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...